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Control of growth and differentiation during mammalian embryogenesis is regulated by
growth factors from embryonic and/or maternal sources. Cytokines are polypeptide growth
factors that are released by a variety of activated immune and nonimmune cells. To identify
novel members of the cytokine family that could be involved in the growth and
differentiation of the preimplantation embryo, we studied the expression pattern of several
genes encoding cytokines and their receptors during mouse preimplantation development
in vitro. We found that poly(A) mRNAs for IL-1, IL-3, IL-6, IL-7, and TNFo are
differentially expressed at several stages of mouse preimplantation development, including
unfertilized oocytes. Immunostaining of preimplantation embryos using monoclonal anti-
bodies specific for several cytokines and their receptors revealed that at least some of these
mRNAs are translated into mature proteins during preimplantation development (IL-1,
IL-6, and TNFc). Positive staining for IL-1 and IL-6 receptors was also detected at these
stages of development. The controlled expression of these "inflammatory-type" cytokines
and their receptors suggests a role for these growth factors during the early phases of mouse
ontogeny.
Interleukins, cytokines, preimplantation development.
INTRODUCTION
Preimplantation embryos grow and differentiate in
the absence of exogenous factors in vitro, suggesting
that endogenous factors are able of sustaining em-
bryonic development during the first seven or eight
cleavage divisions (Biggers, 1971). Direct evidence
and indirect evidence indicate that embryos make
growth factors. Indirect evidence comes, among
others, from experiments in which cultured embryos
from around the time of implantation were shown
to produce transforming growth-factor like bioactiv-
ities that promoted anchorage-independent growth
(Rizzino, 1985). Direct evidence comes from studies
of gene expression, mainly performed at the blasto-
cyst stage, that have documented the presence of
transcripts for PDGF, TGFc, TGF, LIF, IL-6, and
T-IFN in preimplantation embryos (Rappolee et al.,
1988; Murray et al., 1990; Rothstein et al., 1992).
Within the group of polypeptide growth factors,
the more restricted cytokine family exhibits hor-
*Corresponding author: Present address: The Center for Blood
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monelike properties that affect numerous organ
systems (Kishimoto et al., 1994). They are expressed
and act on both hematopoietic and non-
hematopoietic cells. Mammalian cytokines include
the interferons (IFNs), the interleukins (ILs), the
colony stimulating factors (CSFs), the transforming
growth factors (TGFs), as well as leukemia inhibi-
tory factor (LIF), tumor necrosis factor (TNF), and
lymphotoxin (LT). There is increasing evidence that
cytokines participate in and modulate several events
of early development and even pregnancy (Tartak-
ovsky and Ben-Yair, 1991). At present, published
data suggest the involvement of cytokines such as
LIF during implantation (Stewart et al., 1992), and
of TGF3 (Clark et al., 1988), and CSF-1 (Arceci et
al., 1989; Chaouat et al., 1990) during postimplan-
tation development. These polypeptide growth fac-
tors are believed to promote placental development,
trophoblast proliferation, and, in the case of TGF3,
to participate also in preventing harmful maternal
antifetal immune responses. Much less is known
about the role of cytokines in the preimplantation
stages of development. LIF retards the differentia-
tion of embryonic stem cells in vitro, but seems to170 N. GERWIN et al.
promote the in vitro development of eight-cell em-
bryos to the posthatching stages (Smith et al., 1988;
Williams et al., 1988; Hilton, 1992). GM-CSF was
demonstrated to have a beneficial effect on the in
vitro development of implanting blastocysts from
morulae (Tartakovsky and Ben-Yair, 1991). Another
earlier study demonstrated that the in vitro growth
of two-cell embryos was inhibited by a variety of
cytokines (Hill et al., 1987).
Also, preimplantation embryos could be accessi-
ble targets for cytokines produced by the placental
microenvironment. The interaction of preimplanta-
tion embryos with these biological-response modi-
fiers or their induced products may well determine,
modulate, or alter their programmed development.
This notion may provide new and interesting in-
sights into early events of mammalian development.
Our study focuses mainly on interleukins and is
aimed to determine which genes encoding this
subfamily of cytokines are expressed during preim-
plantation development. Also, it investigates if these
interleukins are expressed at the protein level and
correlates their expression with the presence of their
specific receptors at different stages of preimplanta-
tion development.
RESULTS AND DISCUSSION
Control of growth and differentiation during mam-
malian embryogenesis is regulated by growth fac-
tors from embryonic or maternal sources. Direct
evidence for growth-factor transcripts of low copy
number is difficult to obtain in preimplantation
embryos, because thousands of embryos are re-
quired to detect high copy-number transcripts such
as those coding for histones or actins by RNA blot
analysis. Thus, for a detailed analysis of the cytokine
gene-expression patterns in these stages, procedures
were required that allow detection of both small
amounts of mRNA as well as minor changes in
interleukin (IL) gene expression. The polymerase
chain reaction (PCR) was chosen because of its high
sensitivity (Saiki et al., 1985). cDNA templates for
PCR amplification were obtained using oligo(dT)-
priming in the reverse-transcription (RT) reaction, in
order to exclude immature or semidegraded poly-
(A)less transcripts in the subsequent PCR analysis.
Also, by demanding amplification between primers
in different exons, the technique detects only prop-
erly spliced mRNAs. Although due to different
affinities of the primers, no comparison can be made
for the level of expression among different cytok-
ines, reproducibility as well as parallel and simulta-
neous processing of all samples for a given pair of
primers allows one to compare the pattern of ex-
pression for a given interleukin in different stages of
development. To ensure further that differences in
the quality of RNA preparations would not affect
PCR amplifications of different samples differen-
tially, titration of cycle number experiments was
performed using ]-actin oligos as primers and
ethidium-bromide stained gels of PCR products
obtained after 15, 20, 25, and 35 cycles of amplifi-
cation (data not shown). Also, given the variability
in the amount of RNA per cell in embryos at
different stages of development (Piko and Clegg,
1982), we titrated the amount of RNA in each
embryo preparation by amplifying the RNA of two
ubiquitously expressed genes, ]-actin and DHFR
(data not shown). Thus, an equivalent amount of
RNA (approximately equivalent to 75 ng of total
RNA) was used finally for each PCR amplification.
The authenticity of the PCR products detected was
determined by hybridization to specific probes that
lie internal to the primers used (Gutierrez-Ramos et
al., 1992). The hybridization signals were propor-
tional to the amount of product run on the gel, after
amplification of a constant amount of cDNA (data
not shown). Irrespective of the primers used, no
PCR products were detected by hybridization if no
RNA was included in the RT reaction prior to
amplification (blank, Fig. 1). The detection of puta-
tive illegitimate transcription (Chelly et al., 1989)
was avoided by using short amplifications (25 cy-
cles), and could be ruled out by the reproducible
lack of amplified bands in the negative control
samples (data not shown). That equivalent amounts
of total cDNA were available to the PCR primers
was confirmed by the capacity to amplify equal
amounts of (ubiquitously expressed) [-actin product
from each sample (Fig. 1).
We first studied cytokine mRNA expression in
mouse preimplantation embryos at different stages
of development. Because oligo(dT) was used to
prime the RT, the amplified fragments have to be
derived from polyadenylated [poly(A) RNA. We
detected poly(A) IL-1], IL-3, and IL-7 transcripts
in the fertilized oocyte, but no transcripts for IL-2,
IL-4, IL-5, IL-6 and TNFx (Fig. 1; data not shown).
Whereas no IL3 poly(A) mRNA at all was detected
in RNA preparations from two-cell stage embryos,
detectable poly(A) mRNAs for IL-1 and IL-7 were
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FIGURE 1. RT-PCR analysis of cytokine mRNA expression by mouse preimplantation embryos. The stage of the preimplantation
embryos analyzed in each lane is indicated by a number, which corresponds to one picture in the top panel of the figure: 1, fertilized
oocyte; 2, two-cell stage; 3, 16-cell stage; 4, compacted morula; 5, early blastocyst; 6, late blastocyst; and 7, expanded blastocyst.
RT-PCR was performed as described in Materials and Methods. The size in base pairs of the amplified cDNA products is indicated
in the margin. Two additional lanes for each cytokine designated as "P" and "B" show positive control and blank respectively.172 N. GERWIN et al.
mRNA species were reduced to approximately 10
and 20%, respectively, of the amount detected in
the fertilized oocyte (Fig. 1).
The fact that most maternal mRNAs are cleaved
and become undetectable around the two-cell stage
(Flach et al., 1982) led us to explore the possible
presence of mRNA for IL-1, IL-3 and IL-7 in
unfertilized oocytes. Some maternal mRNAs are
present in the unfertilized oocyte in a poly(A)less
form (Proudfoot, 1991; Simon et al., 1992). To
ensure that both poly(A) and poly(A)less tran-
scripts could be detected in unfertilized oocytes
during these new series of PCR reactions for inter-
leukin detection, we followed two different strate-
gies to generate cDNA templates, cDNAs from
unfertilized mouse embryos were generated using
oligo(dT) or random hexamers as primers for RT.
Amplification of oligo(dT)-primed cDNAs with spe-
cific cytokine primers only detects poly(A) mRNA,
whereas the use of random hexamers or 3’-specific
primers (data not shown) ensures that both polya-
denylated and non-polyadenylated mRNAs are de-
tected. Figure 2 shows a series of experiments aimed
to detect specific transcripts for IL-1, IL-3, and IL-7
in the poly(A) and/or poly(A)less RNA pools from
fertilized and unfertilized oocytes. We found that
mRNAs for these genes were detectable in unfertil-
ized oocytes only when random-hexamer-primed
cDNAs were used for the PCR and not when
oligo(dT)-primed material was used. This indicates
that mRNA for these three cytokines is present in
the unfertilized oocyte in a poly(A)less form. In
contrast, the mRNAs for these three genes are
present in a poly(A) form in the fertilized oocyte as
indicated by the detection of these mRNA species
independently of the priming strategy used
[(oligo(dT)-primed or random hexamer-primed)] for
the reverse transcription of mRNA from fertilized
oocytes. These findings together with the
disappearance/reduction of IL-1, IL-3, and IL-7
mRNA around the two-cell stage suggest that these
transcripts are of maternal origin. Very early events
in embryonic development take place in the absence
of transcription and depend on information pro-
vided by maternal mRNA and protein (Dworkin and
Dworkin-Rastl, 1990). In Drosophila, development is
under maternal control for the first 13 nuclear
divisions, after which the embryonic genome is
transcriptionally activated. Embryonic transcription
in Xenopus is not required until the midblastula
transition when the embryo consists of approxi-





FIGURE 2. RT-PCR analysis of cytokine mRNA expression by
unfertilized and fertilized oocytes. Fertilized and unfertilized
oocytes were analyzed for the presence of specific mRNA for the
indicated interleukins. For these experiments, RNA was reverse
transcribed, priming either with oligo(dT) or with random hex-
amers as indicated in the figure.
period of exclusive maternal control is shorter, and
in the mouse is believed to last for only one cell
division (Johnson, 1981). Little if any transcription is
detectable until the two-cell stage, and a-amanitine,
a potent inhibitor of RNA-polymerase II, fails to
block the first cell division. Completion of the first
cell division is thought to require translation of at
least some maternally inherited mRNAs. These ex-
periments have suggested that the maternal inher-
itance is required to traverse the first cycle and to
activate transcription from the genome of two-cell
mouse embryos. The finding of IL-1 and IL-3 tran-
scripts in the unfertilized oocyte stage deserves
special attention due to the features of these twoINTERLEUKIN IN PREIMPLANTATION 173
growth factors. IL-1 is a pleiotropic differentiation
factor capable of inducing the expression of other
genes such as c-fos, c-abl, and other protooncogenes
(Lipsky et al., 1983; Botazzi et al., 1990; Callard and
Gearing, 1994). It has been detected in the tropho-
blast and placental tissue of murine embryos as well
as in later stage human embryos (Crainie, 1990).
IL-3 is known to have an impact on the survival and
differentiation of early hematopoietic progenitors
and specific effects on more committed cell lineages
such as mast cells (Arai et al., 1990; Callard and
Gearing, 1994).
We found that cytokine mRNA expression was
also regulated at later stages of preimplantation
development. As stated before, IL-7 mRNA was
detected in unfertilized and fertilized oocytes, dis-
appeared around the two-cell stage, and reappeared
in compacted morulas (Fig. 1). According to our
previous experience with these PCR primers
(Gutierrez-Ramos et al., 1992), the observed differ-
ences in the amount of IL-7 mRNA between oocytes
and morulas indicate that IL-7 transcripts are ten-
fold more abundant in the morula than in the
fertilized oocyte. IL-7 is known to induce the differ-
entiation of immature lymphocytes (Henney, 1989;
Callard and Gearing, 1994; Komschlies et al., 1994),
and to activate directly growth regulatory genes
such as N-myc or c-myc (Morrow et al., 1992).
Transcripts for .IL-6 were identified from the
eight-cell stage of development on (Fig. 1). The
detection of IL-6 transcripts is interesting because
IL-6 is a multifunctional cytokine. It plays a major
role in the inflammatory responses and is the pri-
mary inducer of acute phase proteins (Kishimoto,
1989; Callard and Gearing, 1994). This cytokine
promotes the differentiation and/or proliferation in
vitro and in vivo of cells belonging to several
lineages at different stages of their maturation (Kish-
imoto, 1989). In addition, IL-6 is known to have
effects on the expression of several other genes,
including IL-1 (Shabo et al., 1988). Our results
confirm previous reports describing the presence of
IL-6 transcripts at the blastocyst stage (Murray et al.,
1990; Rothstein et al., 1992), and extends them by
defining the profile of expression of IL-6 at different
stages of preimplantation development.
Although zygotic genome transcription is very
active at the blastocyst stage (Shultz, 1986), it seems
unlikely that preimplantation embryos express these
cytokine genes promiscuously. In fact, four other
cytokine genes (IL-2, IL-3, IL-4, and IL-5), which
are expressed in several tissues in adult mice and/or
in other ontogenic stages, were not found to be
expressed during preimplantation development in
our experiments.
Rappolee et al., (1990) had classified the accumu-
lation patterns of growth factors that do not belong
to the interleukin family into three classes. In one
class, maternal transcripts apparently dissappeared
and were resynthesized in the zygote. In the second
class, some transcripts were not present maternally,
but appeared as the result of zygotic transcription.
In the third class, transcripts such as for the metal-
loproteinase stromyelsin apparently survived the
breakdown of maternal RNAs that occurs in the
two-cell stage (Rappolee et al., 1990). The mRNAs
for cytokines that have been analyzed in this work
seem to belong to the two first classes, unless the
slow disappearance of IL-7 around the two-cell
stage is interpreted as survival of this RNA species.
Because the transcription of growth-factor mRNAs
is not invariably coupled with the translation into
proteins (Assoian et al., 1987), it was necessary to
determine whether the transcripts that were de-
tected by RT-PCR were translated into mature pro-
teins in the preimplantation embryo. However,
these studies were somehow restricted by the avail-
ability of specific monoclonal antibodies only for
some cytokines (see Material and Methods). Immu-
nocytochemistry experiments revealed the presence
of IL-1, IL-6, and TNF proteins in mouse preim-
plantation embryos. Preimplantation embryos rang-
ing from the one-cell stage to the blastocyst stage
were stained with the different antibodies indicated
in the Material and Methods section. Fertilized
oocytes (Fig. 3, panel I) did not show any positive
staining with antibodies specific for IL-4 (Fig. 3c) or
IL-6 (Fig. 3d), whereas staining with antibodies
specific for IL-1 resulted in a strong positive signal
(Fig. 3a), which was not seen in its isotype-matched
irrelevant negative control antibody (Fig. 3b). The
same phenotype was also observed during the
two-cell stage (Fig. 3, panel II). This interesting
pattern of IL-1 staining, together with the availabil-
ity of specific antibodies against the receptors for
IL-1 prompted us to determine if receptors for IL-1
(IL-1R) could be present at the same developmental
stages as its ligand. In fact, positive staining for the
IL-1 receptors (type and/or type II) was observed
both in oocytes and two-cell stage embryos (Figs. 3e
and 3k). No staining was observed at these stages of
preimplantation development when specific anti-
bodies for IL-6 receptors were used (Figs. 3f and 31).
IL-1 has a different intracellular transport pathwayINTERLEUKIN IN PREIMPLANTATION 175
would eventually participate in the endoderm line-
age formation.
The detection of IL-1 and IL-6 proteins in mouse
preimplantation embryos prompted us to determine
the possible presence of TNFc, which together with
IL-1 and IL-6 forms the group of inflammatory
cytokines (Beutler and Cerami, 1989; Callard and
Gearing, 1994). TNFc protein was not detected
before the late blastocyst stage. Staining of late and
expanded blastocysts (panel IV) with anti-TNFc
antibodies resulted in diffuse positive staining of all
blastomeres (data not shown). Specific mRNA for
TNF was also detected by RT-PCR at these late
preimplantation stages (data not shown). The pat-
tern of spatial expression of IL-1 (Fig. 3r) and IL-1R
(Fig. 3u) at the expanded blastocyst stage deserves
special attention. Whereas low levels of IL-1 were
detected uniformly in all blastomeres at this stage,
its receptor(s) were brightly expressed only in few
blastomeres, resulting in a much more restricted
pattern of staining (Fig. 3u). Staining of late and
expanded blastocysts with antibodies specific for
IL-6 or with the irrelevant antibody mentioned
previously did not result in positive signal (Figs. 3t
and 3s, respectively). However, staining of late and
expanded blastocysts with specific antibodies for
IL-6R, resulted in diffused positive staining in vir-
tually all blastomeres (Fig. 3v). Soon after blastocoel
formation and expansion of the blastocyst, the
embryo hatches and implants in the uterine wall.
During implantation, extensive differentiation, pro-
liferation, and tissue remodeling take place, parts of
which resemble inflammatory reactions. TNFc and
IL-1 transcripts have been identified in different
organs of normal rats, and among many other cell
types TNF-c is likely to be produced by cells in the
uterus and placenta during pregnancy. Northern
blotting experiments have identified TNF-c tran-
scripts in murine placental RNA (Crainie, 1990). In
addition, biologically active TNFc and IL-1 have
been reported in human decidua and conditioned
media from human embryos contain immunoreac-
tive TNF- (Witkin et al., 1991).
Most data on growth-factor action in nonmama-
lian early embryos implicate their function in differ-
entiation rather than in mitosis (Rappolee et al.,
1990). Other growth factors, like bFGF or TGF3
appear to be morphogens responsible for the induc-
tion of mesoderm at the blastulation stage, as has
been shown in Xenopus (Kimelman and Kirschner,
1987; Weeks and Melton, 1987). However, the early
development of the mouse has several properties
that distinguish it from that of the frog. For exam-
ple, the mouse egg is small, has little yolk, and
quickly activates zygotic transcription after fertiliza-
tion. The functions of inflammatory cytokines in
preimplantation embryos are as yet unknown, but
might include differential effects on the growth of
blastocyst-derived cells and their expression of classI
MHC, stimulation of angiogenesis, and implantation
of the hatched blastocyst. In addition, the implan-
tation process itself is characterized by very specific
changes in the receptive endometrium, which
include local increase in capillary permeability
and release of histamines and prostaglandins
(Psychoyos, 1986; Yelavarthi et al., 1991). These
changes reflect an inflammatorylike process and as
such, the proinflammatory cytokines IL-1, IL-6, and
TNFc could play an important role. One possibility
is that these cytokines bind to receptor cells, in the
oviduct and/or uterine endometrium and activate,
for example, epithelial cells or macrophages to se-
crete substances that promote development and
subsequent implantation of the early embryo. The
survival of mice that have been made deficient for
these genes (Kopf et al., 1994; Pfeffer et al., 1993;
and Jia and Gutierrez-Ramos, in preparation) sug-
gests that singlely these cytokines are not essential
for embryonic development. However, it remains to
be determined if the concerted action of two or more
of these factors is required for the proper develop-
ment of the mouse preimplantation embryo.
MATERIALS AND METHODS
Preparation of Mouse Embryos and Cultures
Isolation and culture of mouse embryos were per-
formed as described (Hogan et al., 1986). Three-to-
six-week-old (C57BL/6xDBA/2)F1 females kept on
a light cycle from 5 A.M. to 7 P.M., were super-
ovulated by intraperitoneal injection of 5 U per
mouse of gonadotropins from pregnant mare’s se-
rum at 2 P.M., followed 48 hr later by injection of 5 U
per mouse of human chorionic gonadotropin. These
mice were mated overnight with (C57BL/6xDBA/
2)F1 males, and embryos were harvested from
plugged females between 7 A.M. and 9 A.M. the
following morning. Embryos were devoided of sur-
rounding cumulus mass cells by digestion with
hyaluronidase, which was followed by five consec-
utive washes in M2 medium (Hogan et al., 1986).
Embryos were cultured in 90 gl drops of M16176 N. GERWIN et al.
medium (Hogan et al., 1986), covered by paraffin oil
and kept in 7.5% CO2 at 37C. Differential inter-
ference contrast microscopy and microphotography
were performed with a Nikon Diaphot microscope.
Alternatively, embryos at the two-cell and eight-cell
stages (second and third day of pregnancy, respec-
tively) were isolated by flushing M2 medium,
through oviducts. Blastocysts on the fourth day of
pregnancy were isolated by flushing the uterine
horns.
Immunofluorescence
Preimplantation embryos were fixed immediately
after collection or after a 3-to-6-day culture period.
The zona pellucida was not removed. Fixation was
performed in 2% paraformaldehyde/0.1% glutaral-
dehyde in 0.1% phosphate buffered saline (PBS),
pH 7.4, for 30 min at room temperature (RT). After
washing, fixed embryos were treated for 5 min at RT
with a 0.05% solution of sodium borohydride in
PBS without Ca and Mg and washed again.
Cells were permeabilized by incubation for 10 min
at RT in 0.1% Triton X-100 in PBS. After washing,
when the specimens were not previously cultured,
the embryos were preincubated for 60 min at RT in
a 0.5% w/v solution of BSA in DMEM (Hepes
buffered, 25 mM). This solution was also used to
dilute the first antib,ody and the second fluorescein
isothiocyanate (FITC)-coupled goat anti-rat IgG
(H + L) antibody 1:60 (Jackson Immunoresearch, Bar
Harbor, ME). The incubation time for each antibody
was 1 hr at RT. Four washes of 10 rain were
performed between each incubation. Finally, the
specimens were embedded in a 90/10 mixture of
moviol and PBS containing paraphenylenediamine
(Johnson and Nogueira-Araujo, 1981).
Specimens were viewed in a Bio-Rad Lasersharp
MRC-600 Confocal Light Scanning Microscope
(CLSM), and hard copies were obtained in a Sony
color video printer. Microscope settings were kept
identical when comparing test and control samples.
Antibodies
The following monoclonal antibodies were used:
anti-IL-2 (hybridoma $4B6); anti-IL-4 (hybridoma
11Bll; Ohara and Paul, t985); anti-IL-6 (Genzyme,
Boston, MA); anti-IL-6R (which is specific for the
a-chain of the receptor; Genzyme, Boston); anti-
TNF (Genzyme); anti-IL-1 (British Biotechnology,
Oxford UK); anti-IL-1R, which recognizes IL-1R
type and II (Genzyme, Boston). As irrelevant
antibodies isotype-matched negative controls were
used [anti-I1-2Rc; hybridomas PC61 (ratIgG) or 7D4
(ratIgM]). As a second step reagent, a 1:60 dilution
of a goat anti-ratIgG FITC-labeled antibody (Jackson
Immunoresearch) was used.
RT-PCR Analysis
Preimplantation embryos were washed in PBS
twice, resuspended in 40 to 100 tl of DEPC-water
containing 40 U of RNAsin (Promega, Madison, WI)
and boiled for 10 min. The crude material obtained
was RQ1-DNAse-treated (New England Biolabs,
Boston) for 30 min at 37C. After inactivation of the
DNAse, the crude material was reverse transcribed
using oligo(dT)12_15 as a primer and MMLV reverse
transcriptase in a 20 tl reaction (Land et al., 1983).
Four microliters of the reverse-transcribed material
(equivalent to approximately four embryos) were
used directly for the first determination of amplifi-
cation reactions, which were performed using spe-
cific primers for ubiquitous genes to titrate the
amount of RNA in each sample (see Results). Con-
ditions for PCR were as follows: In a 50 tl reaction,
25 nmol of each primer (see what follows), 25 tM of
each dGTP, dATP, dTTP and dCTP; 50 mM KC1,
10 mM Tris-HC1, pH 8.3; 1.5 mM MgCI2; 1 mg/ml
gelatin; and 1 U Taq DNA polymerase ("AmpliTaq"
Perkin-Elmer/Cetus, Norwalk, CT). Primers used
were the following: IL-lc (nucleotides 1573-1595
and 1881-1861; Lomedico et al., 1984), IL-2 (nucle-
otides 203-217 and 370-346; Yokota et al., 1985),
IL-3 (nucleotides 286-310 and 578-555; Yokota et
al., 1984), IL-4 (nucleotides 231-255 and 411-387;
(Lee et al., 1986), IL-5 (nucleotides 1182-1206 and
1424-1400; Yokota et al., 1987); IL-6 (nucleotides
581-605 and 735-711; Chiu et al., 1988), IL-7
(nucleotides 1146-1170 and 1446-1422; (Tokunaga
et al., 1986) and -actin (nucleotides 886-910 and
1234-1210; (Noma et al., 1986). To avoid unspliced
mRNA or DNA (DNAse-resistant) amplification,
each primer of every pair is located in different
exons. In addition, the absence of contaminating
DNA was confirmed by performing PCR amplifica-
tions of intronic sequences of the c-actin gene, as
previously described (Van Meerwijk et al., 1990)
Reactions were incubated in Perkin-Elmer/Cetus
DNA thermal cycler for 25 cycles (denaturation 30 s,
94C; annealing 30 s, 55C; extension 1 min, 72C)
following the manufacturer’s recommendations.
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on a 1.5% agarose gel. Specific amplification was
ensured by the size of the product, as shown on the
gel relative to known standards and by probing the
Southern blots with the following 32p-labeled cDNA
probes: IL-la (0.9 kb BamHI-BamHI; Lomedico et
al., 1984); IL-2 (1 kb XhoI-XhoI; Yokota et al., 1985);
IL-3 (375 bp HindIII-XbaI; Yokota et al., 1984); IL-4
(300 bp RsaI-RsaI; (Van Snick et al., 1988), IL-5 (430
bp XhoI-XhoI; Yokota et al., 1987); IL-6 (650 bp
EcoRI-BglII); IL-7 (450 bp SstI-HindIII; Samaridis
et al., 1991); and [-actin (1.1 kb PstI-PstI). The
probes were isolated fragments labeled with 32P-
dATP by using a random-primer DNA labeling kit
(Boehringer Mannheim, Indianapolis, IN). In every
case hybridization was performed under the same
conditions using the same amount of cpm (3 x 106
cpm/ml of hybridization buffer) followed by stan-
dard washings. In every case, 45 min RT exposures
are shown. Longer exposure did not change the
shown pattern of expression. Longer exposure of
the IL-2- or IL-5-probed filter did not show any
additional bands. Titrations of cycle number showed
that the amount of specific amplified products in-
creased approximately logarithmically up to be-
tween 35 and 40 cycles. Thus, to keep reactions
within nonlimiting conditions and yet obtain detect-
able signals, 25-cycle amplifications were chosen.
PCR products obtained with [-actin primers after
15, 20, 25, and 35 cycles of amplification were
detected with ethidium-bromide stained gels (data
not shown). Densitometric analysis of these [-actin
amplifications showed that the samples had a coef-
ficient of variance of 0.19, which was insignificant
compared to the changes in message levels observed
in different stages of development. As an additional
control, 45 cycles were performed in each experi-
ment (not shown) and processed in parallel to the
"25 cycles experiment", which is shown in Fig. 1.
This set of parallel experiments showed the repro-
ducibility of the assay and as well confirmed the
nonsaturating conditions used for the "25-cycle
experiments" shown here. The sensitivity of our
PCR conditions was estimated by titrating a known
number of copies of the genes analyzed here (cor-
responding plasmids) containing the relevant primer
sites with cDNA known to be negative for the
message of interest. These experiments revealed
that by performing 25-cycle amplifications followed
by hybridization with 45-min exposure, we could
reproducibly detect between 10 and 1000 cDNA
molecules depending of the primers used
(Gutierrez-Ramos et al., 1992). Due to different
efficiencies of the primers, comparisons cannot be
made among different ILs in terms of levels of
expression. However, because all samples for a
given pair of primers were processed simulta-
neously, in parallel with master mixes (including
every reaction component but templates), loaded on
the same gel, and hybridized on the same filters
under non-saturating conditions, comparisons can
be made for the expression of a given IL in different
stages of development.
Two separate controls were performed in every
experiment: A blank tube (every component but
RNA template) and one positive control (1 tg of
RNA from PMA + Ionomycin-stimulated spleen
cells for IL-2, IL-3, IL-4, IL-5 expression, from
LPS-stimulated P388D1 macrophage cell line for
IL-1 and IL-6 expression, from the J558L myeloma
cell line transfected with the mouse cDNA encoding
IL-7 (Samaridis et al., 1991) for IL-7 expression.
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